Packaged food firms are investing heavily in textural engineering and mouthfeel because flavor combinations have reached their practical limit. Consumers seek novel sensory stimulation, prompting complex food science innovations like protective fat layers that keep biscuit pieces crispy within chocolate bars.

While AI dominates headlines, GLP-1 drugs could have a more profound and immediate impact on society. They address the core mechanism of desire ("wanting less"), with applications for obesity, addiction, and compulsive behaviors that could fundamentally reshape public health and daily life.

Research shows that while GLP-1 drug users eat less, they will pay more for high-quality ingredients. This creates a strategic opportunity for restaurants to increase profit margins by offering smaller, premium-priced dishes, tapping into the retail psychology that smaller items can carry a higher proportional markup.

Hershey's direct consumer research reveals that GLP-1 users don't eliminate treats. Instead, they feel a new sense of freedom and confidence, enjoying smaller, portion-controlled versions of their favorite snacks without guilt, which is a resilient behavior for the category.

The widespread adoption of GLP-1 therapies is projected to decrease total U.S. calorie consumption by 1.6% by 2035. This second-order effect will create significant disruption and headwinds for industries reliant on consumer food purchasing, including the CPG, retail, and restaurant sectors.

Our evolutionary instincts for craving scarce resources haven't adapted to the modern world of abundance. GLP-1 drugs provide a biological support system, or "scaffolding," that helps regulate these outdated cravings for things like high-calorie food and other hedonic activities.

The widespread use of GLP-1 drugs like Ozempic has a second-order effect: it dulls users' sense of taste. In response, food giant Nestlé is proactively changing its recipes, adding more salt and spices to brands like Cornflakes and Popsicles to cater to this large and growing consumer segment's altered taste profile.

A significant, under-discussed benefit of weight-loss drugs is the elimination of "food noise"—the constant mental distraction of thinking about food and snacking. This frees up cognitive energy and can reclaim as much as 90 minutes per day.

Drugs like Ozempic shift consumer preference from simple carbs to high-protein foods. This has accelerated beef demand, as users crave items like beef jerky over chips. This counterintuitive trend links pharmaceuticals to agricultural commodity markets.